« Glucagon-like Peptide-1 Receptor Agonist Treatment in Type 1 Diabetes: A Review of Current Evidence and Rationale for Use », Can Diabetes Endocrinol Today, vol. 1, nᵒ 3, p. 21–26, oct. 2023, doi: 10.58931/cdet.2023.1318.